Company research
Moderna, Inc.
CIK 1682852Updated Nov 11, 2026
SecurityMRNA · NASDAQ · equity
Name history
Moderna Therapeutics, Inc. · through Aug 24, 2016
MRNA price & chart
Loading TradingView…
NASDAQ:MRNA on TradingView ↗About the company
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
In the news
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 ↗
Seeking Alpha
ValuEngine Weekly Market Commentary With Outlook For The Remainder Of 2026 ↗
Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focus ↗
Earnings Scorecard: 96% healthcare firms post EPS wins this week ↗
SEC disclosures
Moderna, Inc. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G/A - filed by FMR LLC regarding Moderna, Inc.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Other Events
Items 1.01, 2.03, 3.02, 8.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 12,135,000,000Source | 15,803,000,000Source | 10,961,000,000Source | 12,010,000,000Source | 15,680,000,000Source | 11,488,000,000Source | 12,704,000,000Source | 16,729,000,000Source | 12,338,000,000Source | 14,142,000,000Source | 18,426,000,000Source | 25,858,000,000Source |
| GoodwillUSD | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,132,000,000Source | 1,644,000,000Source | 1,723,000,000Source | 1,279,000,000Source | 2,478,000,000Source | 1,908,000,000Source | 1,623,000,000Source | 2,051,000,000Source | 2,595,000,000Source | 1,927,000,000Source | 2,907,000,000Source | 3,205,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,046,000,000Source | 1,564,000,000Source | 17,000,000Source | 36,000,000Source | 163,000,000Source | 71,000,000Source | 78,000,000Source | 137,000,000Source | 184,000,000Source | 358,000,000Source | 892,000,000Source | 1,385,000,000Source |
| Inventory, NetUSD | 332,000,000Source | 412,000,000Source | 280,000,000Source | 240,000,000Source | 399,000,000Source | 146,000,000Source | 128,000,000Source | 295,000,000Source | 153,000,000Source | 117,000,000Source | 202,000,000Source | 949,000,000Source |
| Assets, CurrentUSD | 6,598,000,000Source | 9,666,000,000Source | 5,815,000,000Source | 6,171,000,000Source | 9,661,000,000Source | 5,770,000,000Source | 6,766,000,000Source | 9,600,000,000Source | 6,544,000,000Source | 8,099,000,000Source | 10,325,000,000Source | 13,431,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 716,000,000Source | 823,000,000Source | 380,000,000Source | 764,000,000Source | 611,000,000Source | 348,000,000Source | 585,000,000Source | 645,000,000Source | 408,000,000Source | 599,000,000Source | 627,000,000Source | 1,195,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 738,000,000Source | 784,000,000Source | 697,000,000Source | 750,000,000Source | 775,000,000Source | 706,000,000Source | 752,000,000Source | 697,000,000Source | 719,000,000Source | 759,000,000Source | 713,000,000Source | 121,000,000Source |
| Other Assets, NoncurrentUSD | 530,000,000Source | 556,000,000Source | 618,000,000Source | 546,000,000Source | 641,000,000Source | 675,000,000Source | 556,000,000Source | 650,000,000Source | 605,000,000Source | 594,000,000Source | 685,000,000Source | 988,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 2,805,000,000Source | 3,876,000,000Source | 4,200,000,000Source | 2,611,000,000Source | 3,968,000,000Source | 4,080,000,000Source | 2,638,000,000Source | 3,912,000,000Source | 3,688,000,000Source | 3,241,000,000Source | 4,572,000,000Source | 6,735,000,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 1,254,000,000Source | 751,000,000Source | 1,644,000,000Source | 1,127,000,000Source | 631,000,000Source | 1,503,000,000Source | 982,000,000Source | 487,000,000Source | 1,382,000,000Source | 866,000,000Source | 371,000,000Source | 1,173,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 8,049,000,000Source | 11,165,000,000Source | 5,098,000,000Source | 8,249,000,000Source | 11,152,000,000Source | 5,880,000,000Source | 9,074,000,000Source | 12,431,000,000Source | 7,223,000,000Source | 10,045,000,000Source | 13,606,000,000Source | 18,320,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 27,000,000Source | 11,000,000Source | 19,000,000Source | 23,000,000Source | -71,000,000Source | 25,000,000Source | 10,000,000Source | -101,000,000Source | 45,000,000Source | -10,000,000Source | -123,000,000Source | -370,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 9,330,000,000Source | 11,927,000,000Source | 6,761,000,000Source | 9,399,000,000Source | 11,712,000,000Source | 7,408,000,000Source | 10,066,000,000Source | 12,817,000,000Source | 8,650,000,000Source | 10,901,000,000Source | 13,854,000,000Source | 19,123,000,000Source |
| Liabilities and EquityUSD | 12,135,000,000Source | 15,803,000,000Source | 10,961,000,000Source | 12,010,000,000Source | 15,680,000,000Source | 11,488,000,000Source | 12,704,000,000Source | 16,729,000,000Source | 12,338,000,000Source | 14,142,000,000Source | 18,426,000,000Source | 25,858,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,681,000,000Source | 2,201,000,000Source | 2,534,000,000Source | 1,572,000,000Source | 2,363,000,000Source | 2,395,000,000Source | 1,604,000,000Source | 2,380,000,000Source | 1,987,000,000Source | 2,206,000,000Source | 3,015,000,000Source | 4,923,000,000Source |
| Operating Lease, Liability, CurrentUSD | 17,000,000Source | 21,000,000Source | 21,000,000Source | 16,000,000Source | 25,000,000Source | 19,000,000Source | 15,000,000Source | 25,000,000Source | 17,000,000Source | 14,000,000Source | 25,000,000Source | 35,000,000Source |
| Accounts Payable, CurrentUSD | 267,000,000Source | 373,000,000Source | 167,000,000Source | 175,000,000Source | 279,000,000Source | 161,000,000Source | 226,000,000Source | 183,000,000Source | 317,000,000Source | 405,000,000Source | 520,000,000Source | 487,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 660,000,000Source | 679,000,000Source | 638,000,000Source | 666,000,000Source | 668,000,000Source | 645,000,000Source | 667,000,000Source | 637,000,000Source | 653,000,000Source | 671,000,000Source | 643,000,000Source | 92,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 239,000,000Source | 241,000,000Source | 255,000,000Source | 237,000,000Source | — | 253,000,000Source | 234,000,000Source | — | 249,000,000Source | 231,000,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 281,000,000Source | 276,000,000Source | 284,000,000Source | 276,000,000Source | 266,000,000Source | 283,000,000Source | 274,000,000Source | 262,000,000Source | 285,000,000Source | 267,000,000Source | 256,000,000Source | 135,000,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | 1,046,000,000Source | 1,564,000,000Source | 17,000,000Source | 36,000,000Source | 163,000,000Source | 71,000,000Source | 78,000,000Source | 137,000,000Source | 184,000,000Source | 358,000,000Source | 892,000,000Source | — |
| Accrued Liabilities, CurrentUSD | 1,178,000,000Source | 1,376,000,000Source | 1,909,000,000Source | 987,000,000Source | 1,333,000,000Source | 1,912,000,000Source | 1,001,000,000Source | 1,396,000,000Source | 1,386,000,000Source | 1,427,000,000Source | 1,798,000,000Source | 2,101,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 591,000,000Source | — | — | 590,000,000Source | — | — | 590,000,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 51,000,000Source | 51,000,000Source | 56,000,000Source | 56,000,000Source | 56,000,000Source | 38,000,000Source | 211,000,000Source | 185,000,000Source | 617,000,000Source | 348,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 104,000,000Source | 115,000,000Source | 483,000,000Source | 429,000,000Source | 305,000,000Source | 226,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -114,000,000Source | -280,000,000Source | -156,000,000Source | -534,000,000Source | -493,000,000Source | -1,790,000,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -6,000,000Source | 8,000,000Source | 34,000,000Source | -83,000,000Source | -747,000,000Source | -492,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -120,000,000Source | -156,000,000Source | -92,000,000Source | -69,000,000Source | 13,000,000Source | 240,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 10,000,000Source | -1,000,000Source | 901,000,000Source | -578,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -630,000,000Source | -1,037,000,000Source | -1,873,000,000Source | -3,004,000,000Source | -3,118,000,000Source | 4,981,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 85,000,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -76,000,000Source | 730,000,000Source | 1,946,000,000Source | 1,949,000,000Source | 4,206,000,000Source | -5,176,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 62,000,000Source | 117,000,000Source | 192,000,000Source | 1,051,000,000Source | 707,000,000Source | 400,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 2,000,000Source | 0Source | 1,153,000,000Source | 3,329,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 17,000,000Source | 4,000,000Source | 593,000,000Source | 56,000,000Source | -1,377,000,000Source | -3,448,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -688,000,000Source | -303,000,000Source | 668,000,000Source | -999,000,000Source | -289,000,000Source | -3,643,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,134,000,000Source | 1,647,000,000Source | 1,724,000,000Source | 1,281,000,000Source | 1,909,000,000Source | 1,626,000,000Source | 2,597,000,000Source | 1,929,000,000Source | 2,928,000,000Source | 3,217,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 10,000,000Source | 24,000,000Source | 39,000,000Source | 25,000,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 26,000,000Source | 197,000,000Source | -357,000,000Source | 2,729,000,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 125,000,000Source | 112,000,000Source | 120,000,000Source | 130,000,000Source | 104,000,000Source | 115,000,000Source | 483,000,000Source | 429,000,000Source | 305,000,000Source | 226,000,000Source |
| Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously RecordedUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 3,000,000Source | -8,000,000Source | 0Source | -8,000,000Source | -2,000,000Source | -8,000,000Source | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| General and Administrative ExpenseUSD | — | — | 268,000,000Source | 281,000,000Source | 216,000,000Source | 230,000,000Source | 173,000,000Source | 212,000,000Source | 1,018,000,000Source | 1,174,000,000Source | 1,549,000,000Source | 1,132,000,000Source |
| GoodwillUSD | — | — | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | 52,000,000Source | — |
| Income (Loss) from Equity Method Investments, Net of Dividends or DistributionsUSD | — | — | — | — | — | — | -2,000,000Source | -8,000,000Source | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 13,000,000Source | 8,000,000Source | 15,000,000Source | 7,000,000Source | 9,000,000Source | 7,000,000Source | 54,000,000Source | -46,000,000Source | 772,000,000Source | 1,213,000,000Source |
| Inventory Write-downUSD | — | — | 67,000,000Source | 214,000,000Source | 41,000,000Source | 38,000,000Source | 38,000,000Source | 42,000,000Source | 291,000,000Source | 495,000,000Source | 2,200,000,000Source | 1,300,000,000Source |
| Investment Income, InterestUSD | — | — | 73,000,000Source | 103,000,000Source | 67,000,000Source | 81,000,000Source | 72,000,000Source | 90,000,000Source | 314,000,000Source | 425,000,000Source | 421,000,000Source | 200,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -200,000,000Source | 13,000,000Source | -782,000,000Source | -825,000,000Source | -1,343,000,000Source | -971,000,000Source | -2,822,000,000Source | -3,561,000,000Source | -4,714,000,000Source | 8,362,000,000Source |
| Other Depreciation and AmortizationUSD | — | — | — | — | — | — | 59,000,000Source | 39,000,000Source | 215,000,000Source | 189,000,000Source | 621,000,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | 0Source | -12,000,000Source | -19,000,000Source | 8,000,000Source | -18,000,000Source | -4,000,000Source | -8,000,000Source | -87,000,000Source | -124,000,000Source | -45,000,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 732,000,000Source | 1,933,000,000Source | 5,563,000,000Source | 5,562,000,000Source | 5,575,000,000Source | 3,151,000,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 17,000,000Source | 42,000,000Source | 25,000,000Source | 50,000,000Source |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 1,016,000,000Source | 1,862,000,000Source | 145,000,000Source | 142,000,000Source | 389,000,000Source | 108,000,000Source | 1,944,000,000Source | 3,236,000,000Source | 6,848,000,000Source | 19,263,000,000Source |
| Cost of RevenueUSD | — | — | 207,000,000Source | 514,000,000Source | 93,000,000Source | 119,000,000Source | 955,000,000Source | 90,000,000Source | 868,000,000Source | 1,464,000,000Source | 4,693,000,000Source | 5,416,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -260,000,000Source | -70,000,000Source | -815,000,000Source | -907,000,000Source | -1,388,000,000Source | -1,050,000,000Source | -3,074,000,000Source | -3,945,000,000Source | -4,239,000,000Source | 9,420,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 0Source | -12,000,000Source | -19,000,000Source | 8,000,000Source | -18,000,000Source | -4,000,000Source | -8,000,000Source | -87,000,000Source | -124,000,000Source | -45,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -187,000,000Source | 21,000,000Source | -767,000,000Source | -818,000,000Source | -1,334,000,000Source | -964,000,000Source | -2,768,000,000Source | -3,607,000,000Source | -3,942,000,000Source | 9,575,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 13,000,000Source | 8,000,000Source | 15,000,000Source | 7,000,000Source | 9,000,000Source | 7,000,000Source | 54,000,000Source | -46,000,000Source | 772,000,000Source | 1,213,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -200,000,000Source | 13,000,000Source | -782,000,000Source | -825,000,000Source | -1,343,000,000Source | -971,000,000Source | -2,822,000,000Source | -3,561,000,000Source | -4,714,000,000Source | 8,362,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.51Source | 0.03Source | -1.97Source | -2.13Source | -3.4Source | -2.52Source | -7.26Source | -9.28Source | -12.33Source | 21.26Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.51Source | 0.03Source | -1.97Source | -2.13Source | -3.4Source | -2.52Source | -7.26Source | -9.28Source | -12.33Source | 20.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 390,000,000Source | 385,000,000Source | 398,000,000Source | 388,000,000Source | 395,000,000Source | 386,000,000Source | 389,000,000Source | 384,000,000Source | 382,000,000Source | 394,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 390,000,000Source | 399,000,000Source | 398,000,000Source | 388,000,000Source | 395,000,000Source | 386,000,000Source | 389,000,000Source | 384,000,000Source | 382,000,000Source | 416,000,000Source |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | 1,276,000,000Source | 1,932,000,000Source | 960,000,000Source | 1,049,000,000Source | 1,777,000,000Source | 1,158,000,000Source | 5,018,000,000Source | 7,181,000,000Source | 11,087,000,000Source | 9,843,000,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 44,000,000Source | -45,000,000Source | -129,000,000Source | 1,791,000,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 3,000,000Source | -8,000,000Source | 0Source | -8,000,000Source | -2,000,000Source | -8,000,000Source | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| General and Administrative ExpenseUSD | — | — | 268,000,000Source | 281,000,000Source | 216,000,000Source | 230,000,000Source | 173,000,000Source | 212,000,000Source | 1,018,000,000Source | 1,174,000,000Source | 1,549,000,000Source | 1,132,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -2,655,000,000Source | -3,697,000,000Source | -4,056,000,000Source | 9,433,000,000Source |
| Investment Income, InterestUSD | — | — | 73,000,000Source | 103,000,000Source | 67,000,000Source | 81,000,000Source | 72,000,000Source | 90,000,000Source | 314,000,000Source | 425,000,000Source | 421,000,000Source | 200,000,000Source |
| Research and Development ExpenseUSD | — | — | 801,000,000Source | 1,137,000,000Source | 651,000,000Source | 700,000,000Source | 649,000,000Source | 856,000,000Source | 3,132,000,000Source | 4,543,000,000Source | 4,845,000,000Source | 3,295,000,000Source |
Filing attachments
d18337dex991.htm · 8-K · 2026-09-30
Exhibit 99.1 Moderna Adds Chief Operating Officer Role as Company Expands into Oncology Juan Andres to Return to Moderna as Chief Operating Officer Jerh Collins to Retire Following Four Years of Leadership at Moderna CAMBRIDGE, MA / ACCESS Newswire / September 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the addition of a Chief Operating Officer role to support the increasing scale and diversification of the Company. The new role comes as Moderna prepares for the potential launch …
Read attachment ↗d108896dex41.htm · 8-K · 2026-09-01
Exhibit 4.1 MODERNA, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 1, 2026 0.00% Convertible Senior Notes due 2032 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions …
Read attachment ↗d108896dex991.htm · 8-K · 2026-09-01
Exhibit 99.1 Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes Proceeds to be utilized for general corporate purposes which may include the flexibility to invest in the growth of our oncology business and repayment of debt Moderna will also purchase a hedge overlay intended to offset dilution up to a cap initially equal to at least a 150% premium to the stock price at pricing CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA…
Read attachment ↗d108896dex992.htm · 8-K · 2026-09-01
Exhibit 99.2 Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes Proceeds to be utilized for general corporate purposes which may include the flexibility to invest in the growth of our oncology business and repayment of debt Moderna has also purchased a hedge overlay intended to offset dilution up to a cap initially equal to a 175.0% premium to the stock price at pricing CAMBRIDGE, MA / ACCESS Newswire / August 28, 2026 / Moderna, Inc. (NASDAQ:MRNA) (“Moder…
Read attachment ↗